Modeyso™ approved as the first and only treatment for recurrent H3 K27M-mutant DMG – Zepzelca® and atezolizumab (Tecentriq®) combination approved as maintenance therapyin 1L ES-SCLC – 3Q25 total revenues increased 7% year-over-year driven by robust growth ofEpidiolex®, Xywav® and the launch of Modeyso – Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the […]
Miami International Holdings, Inc. (MIAX) (NYSE: MIAX), a technology-driven leader in building and operating regulated financial markets across multiple asset classes, today reported October 2025 trading results for its U.S. exchange subsidiaries – MIAX®, MIAX Pearl®, MIAX Emerald® and MIAX Sapphire® (collectively, the MIAX Exchange Group), and MIAX Futures™. https://mma.prnewswire.com/media/2635716/MIAX_new_Logo.jpg October 2025 and Year-to-Date Highlights
Hamilton Beach Brands Holding Company (NYSE: HBB) (The Company) today announced results for the third quarter of 2025. ThirdQuarter 2025 Overview — Revenue declined 15.2% to $132.8 million compared to $156.7 million — Gross margin decreased to 21.1% compared to 28.0%; 3Q25 gross margin included a one-time 370 basis point impact mostly from the flow
— Third quarter net revenue of $1.86 billion, up 2% year-over-year; ADI and Products & Solutions (“P&S”) each grew net revenue 2% year-over-year — Record high third quarter gross margin was 29.8%, up 110 basis points year-over-year; year-over-year margin expansion achieved at P&S (ten consecutive quarters) and at ADI (six consecutive quarters) — Record high
(NASDAQ:RELY), SEATTLE, Nov. 05, 2025 (GLOBE NEWSWIRE) — Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services that transcend borders, today announced that it will host its first Investor Day since IPO on Tuesday, December 9, 2025 beginning at 10:00 am ET / 7:00 am PT in New York City, NY.
(NYSE:COHR), Q1 REVENUE OF $1.58B, INCREASED 17% Y/Y AND, ON A PRO FORMA BASIS, 19% Y/Y ADJUSTED FOR SALE OF AEROSPACE & DEFENSE BUSINESS Q1 GAAP GROSS MARGIN OF 36.6%, INCREASED 249 bps Y/Y; Q1 NON-GAAP GROSS MARGIN OF 38.7%, INCREASED 200 bps Y/Y Q1 GAAP EPS OF $1.19, IMPROVED $1.23 Y/Y; Q1 NON-GAAP EPS
Safehold Inc. (NYSE: SAFE) reported results for the third quarter 2025. https://mma.prnewswire.com/media/2039387/Safehold__Carbon_Logo.jpg SAFE published a presentation detailing these results which can be found on its website, www.safeholdinc.comin the “Investors” section. Highlights from the earnings announcement include: — Q3'25 revenue was $96.2 million — Q3'25 net income attributable to common shareholders was $29.3 million — Q3'25
Federated Hermes, Inc. (NYSE: FHI), a global leader in active investing, today announced investment management changes that are expected to take place in 2026. The moves include the retirements of five portfolio managers and the related transitions of portfolio managers and team leaders who will step into new roles as part of the firm's long-term
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme” or the “Company”), today announced that it intends to offer, subject to market conditions and other factors, $650 million aggregate principal amount of convertible senior notes due 2031 (the “2031 Notes”) and $650 million aggregate principal amount of convertible senior notes due 2032 (the “2032 Notes” and, together with
TrueCar, Inc., (NASDAQ:TRUE) (the “Company,” “we,” “our,” “us,” or “TrueCar”) today announced financial results for the third quarter ended September 30, 2025. https://mma.prnewswire.com/media/75148/truecar_logo.jpg Selected Third Quarter 2025 Financial Highlights — Total revenue of $43.2 million, down from $47.0 million in the second quarter of 2025 and down from $46.5 million in the third quarter of